Background: Abnormal fetal growth can adversely impact renal development and is associated with increased risks of developing hypertension and chronic kidney disease later in life. A noninvasive, sensitive method of assessing normal and abnormal fetal kidney development is needed. We hypothesise that the renal parenchymal thickness could be used to evaluate the development of the fetal kidneys and provide an indirect estimate of nephron number. This study uses antenatal ultrasound to assess fetal renal parenchymal growth and determine if abnormal fetal growth affects renal parenchymal thickness. The relationship between renal parenchymal thickness, renal artery Doppler, other fetal Dopplers and amniotic fluid levels will also be evaluated.
Australian National University Medical School, Canberra, ACT, Australia, 2606 Email: margaret.broom@act.gov.au Background: Neonatal death is a regular occurrence in a Neonatal Intensive Care Unit (NICU). However there remains a paucity of evidence to inform the development of services and education for staff caring for dying babies and their families. Current literature focuses on education with limited literature considering how to facilitate best practice, support staff and foster team resilience through experience driven learning. The aim of this study was to develop the components of an education and support package for NICU/SCN Staff based on staff and family experience.
Methods: This study is aligned with principles of Experience Based Co-Design a qualitative approach that seeks to capture the experiences of families and staff through methods such as survey of staff attitudes, observation of practice, group discussion and filmed interviews with both staff and bereaved families.
Results: 18 interviews were held over 2 months. Results identified differing experience and needs for novice, intermediate and senior staff. Core themes revolved around education, support and resources. Factors highlighted include: communication, clinical care, team members roles and responsibilities, self-care, managing conflict, strategies and resources to support families and staff. Currently we are drafting an educational video that will incorporate clinical, psychosocial and leadership components. We are developing a package that will include pathways, multidisciplinary study days and a structured debriefing process.
Conclusion: Staff carry a physical and emotional burden from caring for dying infants, it is essential to have strong processes and strategies to reduce the impact on their clinical practice and overall wellbeing. Background: Fetal growth restriction (FGR) is associated with decreased insulin secretory capacity in adulthood. Intra-amniotic IGF-I treatment of FGR lambs altered size at birth in a sex-specific manner. We investigated whether IGF-I treatment mitigated the negative effects of FGR on the endocrine pancreas at 18-months of age.
SEXUALLY DIMORPHIC EFFECTS OF INTRA-AMNIOTIC IGF-I TREATMENT OF FETAL GROWTH RESTRICTION ON OVINE ENDOCRINE PANCREAS
Methods: Singleton-bearing ewes underwent uterine artery embolisation between 103-107 days' gestational age, followed by five once-weekly intra-amniotic doses of 360 μg IGF-I (FGR-IGF-I: female n = 8, male n = 8), or saline (FGR-Saline: female n = 9, male n = 7), compared to an unmanipulated group (Control: female n = 8, male n = 8). Tissues were collected at 18-months of age. Insulin, glucagon, and somatostatin were visualised via whole-slide imaging for five formalin-fixed sections per pancreas. Snap-frozen whole-pancreas underwent RT-qPCR for 14 genes, normalised to a panel of reference genes (alpha = 0.01).
Results: Pancreas weight was not different amongst groups. Total islet cell mass, β-, or δ-cell mass were not different between groups. Total α-cell mass was increased 225% in FGR-IGF-I vs. Control males only. Genes involved in glucose-stimulated insulin secretion (GSIS) and mitochondrial activity showed overall increased expression in FGR-IGF-I vs. Control females. In contrast, expression of these genes were increased in FGR-Sal vs. Control males, and displayed minimal changes in FGR-IGF-I vs. Control males.
Conclusions: Intra-amniotic IGF-I treatment of the FGR lamb had sexually dimorphic effects on α-cell mass and the expression of genes involved with GSIS at 18-months of age. The sexspecific effects of this antenatal treatment support the need for preclinical studies to be performed in both female and male subjects.
